Insider Transactions in Q4 2021 at Crinetics Pharmaceuticals, Inc. (CRNX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2021
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,000
-2.09%
|
$81,000
$27.95 P/Share
|
|
Dec 15
2021
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,668
-3.81%
|
$136,032
$24.14 P/Share
|
|
Dec 01
2021
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,668
-3.67%
|
$153,036
$27.38 P/Share
|
|
Nov 16
2021
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,500
-0.96%
|
$40,500
$27.97 P/Share
|
|
Nov 15
2021
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,668
-3.5%
|
$147,368
$26.75 P/Share
|
|
Nov 08
2021
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,900
-2.35%
|
$109,200
$28.42 P/Share
|
|
Nov 05
2021
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,600
-7.07%
|
$340,200
$27.95 P/Share
|
|
Nov 01
2021
|
Matthew K Fust |
SELL
Open market or private sale
|
Direct |
8,954
-41.67%
|
$223,850
$25.5 P/Share
|
|
Nov 01
2021
|
Matthew K Fust |
BUY
Exercise of conversion of derivative security
|
Direct |
8,954
+29.41%
|
$8,954
$1.91 P/Share
|
|
Nov 01
2021
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,668
-3.08%
|
$136,032
$24.79 P/Share
|
|
Oct 28
2021
|
Ajay Madan Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
106,383
+36.55%
|
$0
$0.73 P/Share
|
|
Oct 27
2021
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,000
-1.61%
|
$72,000
$24.0 P/Share
|
|
Oct 25
2021
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,200,000
+18.86%
|
$22,800,000
$19.8 P/Share
|
|
Oct 21
2021
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,042
-0.55%
|
$21,882
$21.1 P/Share
|